ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,801,665 Value ($000) $43,146 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 2,553,014 Value ($000) $52,260 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 2,410,636 Value ($000) $48,357 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 1,972,239 Value ($000) $38,814 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 1,975,655 Value ($000) $44,452 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 1,920,372 Value ($000) $49,046 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 1,821,460 Value ($000) $42,568 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 1,183,266 Value ($000) $20,814 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 1,230,888 Value ($000) $17,035 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 1,151,817 Value ($000) $15,734 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 1,142,504 Value ($000) $23,319 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 151,914 Value ($000) $3,327 Avg Close $20.34 Range $14.56 - $25.34